Testing an AI emotional support companion for university students' psychological wellbeing and mental health

ISRCTN ISRCTN61075527
DOI https://doi.org/10.1186/ISRCTN61075527
Secondary identifying numbers p_2024178
Submission date
07/05/2025
Registration date
12/05/2025
Last edited
12/05/2025
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
University students often experience emotional distress but may not have access to or seek traditional mental health support. This study tests whether an AI-based emotional support companion called Kai can help improve psychological wellbeing, including anxiety, depression, PTSD symptoms, and substance use. Through two related experiments, we will compare this digital approach with traditional face-to-face group therapy, individual university counseling services, and a waitlist control group to understand its effectiveness and identify who benefits most from each intervention approach.

Who can participate?
For the first experiment: University students aged 18-35 experiencing mild-to-moderate emotional distress, fluent in Hebrew, with access to digital devices, and not currently receiving mental health treatment.
For the second experiment: Similar criteria, but participants must also be eligible for university counseling services and not have previously used these services within the past year.

What does the study involve?
The study involves two related experiments. In Experiment 1, participants will be randomly assigned to one of three groups: (1) using the Kai AI companion for emotional support for 12 weeks, (2) attending 12 weekly 90-minute group therapy sessions over 12 weeks, or (3) joining a waitlist control group that receives no intervention during the study period but is offered access after completion.
Experiment 2 will include three groups: (1) using the Kai AI companion, (2) receiving traditional face-to-face therapy through the university's Student Counseling Services, and (3) a waitlist control group. We will measure psychological outcomes including anxiety, depression, well-being, PTSD symptoms, and substance use at the beginning and end of the study.

What are the possible benefits and risks of participating?
Potential benefits include improved psychological wellbeing, reduced symptoms of anxiety and depression, and access to support that might otherwise be unavailable. Risks are minimal but may include some emotional discomfort when discussing personal issues, and there's a possibility that the interventions may not be effective for everyone.

Where is the study run from?
The study will be conducted at Reichman University in Israel.

When is the study starting and how long is it expected to run for?
October 2024 to August 2025.

Who is funding the study?
This study is investigator initiated and self-funded without external financial support. Participants will receive academic credits for their participation as part of university coursework requirements.

Who is the main contact?
Prof. Anat Shoshani, Reichman University, ashoshani@runi.ac.il

Contact information

Prof Anat Shoshani
Public, Scientific, Principal Investigator

Baruch Ivcher School of Psychology, Reichman University P.O.Box 167
Herzliya
46150
Israel

ORCiD logoORCID ID 0000-0001-6234-7956
Phone +972 9 9602887
Email ashoshani@runi.ac.il

Study information

Study designA three-arm parallel-group randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)University/medical school/dental school
Study typePrevention, Treatment
Participant information sheet 47296 Participant Information Sheet.pdf
Scientific titleEffectiveness of Kai AI Companion compared to traditional therapeutic approaches for improving psychological wellbeing among university students experiencing mild-to-moderate emotional distress: A comprehensive two-experiment randomized controlled trial
Study acronymKAI-SUPPORT
Study objectives1. Primary Hypotheses:
1.1. University students using the Kai AI companion will show significantly greater improvements in anxiety, depression, and wellbeing compared to waitlist controls.
1.2. The effectiveness of the Kai AI companion for improving psychological outcomes will be comparable to or exceed face-to-face group (Exp 1) or individual (Exp 2) therapy across multiple mental health domains.
1.3. Kai AI intervention will significantly reduce substance use behaviors compared to both face-to-face group therapy and waitlist control conditions (Exp 1).
1.4. Users of the Kai AI companion will report decreased intention to seek traditional therapy compared to participants in the face-to-face therapy and waitlist control groups.

2. Moderation Hypotheses:
2.1. The effectiveness of the Kai AI intervention will be moderated by relational factors, with participants reporting higher loneliness, lower social support, and higher attachment insecurity (both anxious and avoidant) showing stronger intervention benefits, particularly for anxiety outcomes.
2.2. Life events exposure will moderate intervention effectiveness, with participants reporting higher exposure to negative life events and political stressors showing more substantial benefits from Kai AI intervention, especially for anxiety and depression outcomes.

3. Mediation and Engagement Hypotheses:
3.1. Higher engagement with Kai (measured by message frequency) will be associated with greater improvements in mental health outcomes.
3.2. Therapeutic alliance (perceptions of Kai's professional competence and empathy) will predict user engagement, which will in turn mediate mental health improvements.
3.3. Mental health improvements through Kai usage will mediate reductions in perceived need for traditional therapy.
Ethics approval(s)

Approved 08/10/2024, Institutional review board , the Baruch Ivcher School of Psychology, Reichman University (Ha-Universita Street 8, Herzliya, 4610101, Israel; +972 9 952-7223; psylab-manager@runi.ac.il), ref: P_2024178

Health condition(s) or problem(s) studiedAnxiety, Depression, Psychological Distress, PTSD Symptoms, Substance Use
InterventionExperiment 1:
The study comprises three arms:
1. Kai AI Companion (Experimental): Participants will use Kai, a digital AI companion, daily for three months. Kai offers empathetic, affirming, and non-judgmental dialogue based on evidence-based psychological principles including CBT, ACT, and positive psychology. Users will engage with features including daily check-ins, mood tracking, mindfulness and positive psychology exercises, and progress monitoring, with the system continuously adapting to user engagement patterns to maintain effectiveness. Recommended use is ≥3 times/week for 10–15 minutes/session.
2. Face-to-Face Group Intervention (Active Comparator): Participants will attend 12 weekly 90-minute group sessions over 3 months with a psychologist (20 participants per group). Sessions incorporate CBT, ACT, mindfulness, and positive psychology approaches.
3. Waitlist Control: Participants receive no intervention during the 3-month study period but are offered access to an intervention after study completion.
Randomization will be conducted using a computer-generated sequence with allocation concealed in sealed envelopes. Only the outcomes assessor will be blinded to treatment allocation.

Experiment 2:
A second experiment will be conducted with three groups:
Kai AI Companion (Experimental): Same intervention as in Experiment 1.
University Student Counseling Services (Active Comparator): Participants will receive traditional face-to-face therapy through the university's Student Counseling Services.This will involve standard individual counseling sessions following the established protocols of the university counseling services (3 month, once a week)
Waitlist Control: Same as in Experiment 1.
Intervention typeBehavioural
Primary outcome measure1. Life Satisfaction measured using the Brief Multidimensional Students' Life Satisfaction Scale (BMSLSS) at baseline and 3 months
2. Anxiety measured using the Generalized Anxiety Disorder-7 (GAD-7) at baseline and 3 months
3. Depression measured using the Patient Health Questionnaire (PHQ-9) at baseline and 3 months
4. Well-Being measured using the WHO-5 Well-Being Index at baseline and 3 months
5. PTSD Symptoms measured using the PCL-5 (4-item version) at baseline and 3 months
6. Substance Use measured using the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) at baseline and 3 months
Secondary outcome measures1. Help-Seeking Intention measured using the General Help Seeking Questionnaire at baseline and 3 months
2. Engagement with Kai measured by number of messages sent throughout intervention period
3. Perceptions of Kai's Supportive Qualities measured using an adapted version of Cash's Perceptions of Counselor Behavior scale at 3 months
Overall study start date01/10/2024
Completion date02/08/2025

Eligibility

Participant type(s)Learner/student
Age groupAdult
Lower age limit18 Years
Upper age limit35 Years
SexBoth
Target number of participantsExperiment 1: 984 participants (approximately 328 per group) Experiment 2: 164 participants (approximately 55 per group)
Key inclusion criteriaExperiment 1 - Participant inclusion criteria:
1. University students aged 18-35 years
2. Self-reported mild-to-moderate emotional distress (anxiety, sadness, stress)
3. Fluent in Hebrew
4. Access to smartphone or computer with internet
5. Willing to provide informed consent
6. Available to participate in weekly group sessions (for those assigned to group intervention)

Experiment 2 - Participant inclusion criteria:
1. University students aged 18-35 years
2. Self-reported mild-to-moderate emotional distress (anxiety, sadness, stress)
3. Fluent in Hebrew
4. Access to smartphone or computer with internet
5. Willing to provide informed consent
6. Eligible for university counseling services
7. Not previously enrolled in university counseling services
Key exclusion criteriaExperiment 1 - Participant exclusion criteria:
1. Active suicidal ideation or psychiatric crisis
2. Currently receiving psychotherapy or psychiatric medication
3. Diagnosed with severe mental disorder (psychosis, bipolar disorder)
4. Unable to commit to 12-week intervention period
5. Previous participation in similar group intervention programs

Experiment 2 - Participant exclusion criteria:
1. Active suicidal ideation or psychiatric crisis
2. Currently receiving psychotherapy or psychiatric medication
3. Diagnosed with severe mental disorder (psychosis, bipolar disorder)
4. Previous participation in university counseling services within the past year
5. Current enrollment in other intervention studies
Date of first enrolment10/05/2025
Date of final enrolment02/08/2025

Locations

Countries of recruitment

  • Israel

Study participating centre

Reichman University
PO Box 167, 8 Ha'universita Street
Herzliya
4610101
Israel

Sponsor information

Reichman University
University/education

Box 167, 8 Ha'universita Street
Herzliya
4610101
Israel

Phone +972 9 9502426
Email research@runi.ac.il
Website https://www.runi.ac.il
ROR logo "ROR" https://ror.org/01px5cv07

Funders

Funder type

Other

Investigator initiated and funded

No information available

Results and Publications

Intention to publish date02/08/2026
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in high-impact peer-reviewed journals with separate papers analyzing:

Primary outcomes paper examining the effectiveness of Kai AI compared to face-to-face group intervention and waitlist control for mental health outcomes (anxiety, depression, PTSD, well-being) in Experiment 1.
Secondary outcomes paper comparing Kai AI to university counseling services for mental health outcomes in Experiment 2.
Substance use outcomes paper analyzing the effects of Kai AI on substance use patterns compared to both face-to-face interventions across both experiments.
Moderator analysis paper investigating for whom the interventions work best (attachment style, social support, loneliness) in Experiment 1.
Mediator analysis paper examining mechanisms of action in the Kai AI intervention (engagement patterns, perceptions of supportive qualities).
IPD sharing planThe datasets generated during and/or analyzed during the current study will be available upon request from Prof. Anat Shoshani, ashoshani@runi.ac.il

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet 12/05/2025 No Yes
Protocol file 12/05/2025 No No

Additional files

47296 Participant Information Sheet.pdf
47296 Research Protocol Testing an AI emotional support companion .pdf

Editorial Notes

08/05/2025: Trial's existence confirmed by Reichman University.